IM Cannabis Q3 net loss widens to C$7.08M as revenue falls 68%

Image
IM Cannabis Q3 net loss widens to C$7.08M as revenue falls 68%

VANCOUVER — November 13, 2026 -- IM Cannabis Corp. (NASDAQ: IMCC) reported a third-quarter 2026 net loss of C$7.08 million, up about 83% from C$3.87 million a year earlier, as revenue fell about 68% to C$1.65 million from C$5.08 million.

The company also booked a gross loss of C$35,000 in the quarter, equal to about 2% of revenue by FairsOnline's calculation. The third quarter alone accounts for about 51% of the C$13.93 million net loss for the first nine months.

Nine-month net loss reaches C$13.93 million, 3.6 times the 2025 figure

Net loss for the first nine months of 2026 compares with C$3.88 million in the same period of 2025. Revenue for the nine months fell about 43%, to C$8.96 million from C$15.77 million.

Because the third-quarter 2025 loss was C$3.87 million of that period's C$3.88 million, the first half of 2025 works out to a loss of about C$0.01 million. The first half of 2026 works out to a loss of about C$6.85 million. Third-quarter revenue made up about 18% of the 2026 nine-month total.

IM Cannabis completed the sale of its European operations on September 29, 2026

The buyer is Slil.com Holding Ltd. The perimeter includes the German subsidiary Adjupharm GmbH. The company retained its Israeli medical cannabis operations after a restructuring.

Consideration comprises a C$3 million advance payment and the assumption of certain liabilities of up to C$9.4 million, or up to C$12.4 million combined by FairsOnline's calculation. The company expects the transaction to improve shareholders' equity by approximately C$3 million.

The retained business imports and distributes cannabis to medical patients in Israel and runs retail pharmacies and online platforms there. The release's risk section cites the company's liquidity position, going concern disclosure, debt obligations and its ability to maintain or regain compliance with Nasdaq listing requirements.

IM Cannabis negotiates a 51% stake in Polish drone distributor SDI

In September 2026, the company announced a non-binding agreement to acquire 51% of Space Defense Innovations LLC (SDI). SDI operates in unmanned aerial systems through its subsidiary BlueAero Group, which distributes tactical UAS products made by BlueBird Aero Systems. The company did not disclose the price or terms of the stake.

IM Cannabis is negotiating a definitive share purchase agreement with SDI's shareholders.

Published by:
fairsonline_team